Understanding the evidence base for new therapies is critical for informed clinical practice. This module outlines the key efficacy and safety results from the phase 3 clinical trials of fezolinetant and elinzanetant, which resulted in their authorization by Health Canada for the management of VMS.
Summarizing the Efficacy and Safety Results of Fezolinetant and Elinzanetant
CAN-eng
$0
gratuit
Non accrédité
7 min
Santé des femmes
0 Crédits
Description du cours
Détails du cours
Date d'expiration : 2027-02-06
Métiers: Physician, Nursing, Allied Health, Medical Resident, Student, Specialist
Faculté
Accréditation
Objectif(s) d'apprentissage
After viewing this microlearning, participants will be better able to:
- Résumer the efficacy and safety results from trials of fezolinetant and elinzanetant